{"id":"https://openalex.org/W2270944813","doi":"https://doi.org/10.1177/204748730000700608","title":"Rationale, Design and Organization of the Second Chinese Cardiac Study (CCS-2): A Randomized Trial of Clopidogrel plus Aspirin, and of Metoprolol, among Patients with Suspected Acute Myocardial Infarction","display_name":"Rationale, Design and Organization of the Second Chinese Cardiac Study (CCS-2): A Randomized Trial of Clopidogrel plus Aspirin, and of Metoprolol, among Patients with Suspected Acute Myocardial Infarction","publication_year":2000,"publication_date":"2000-12-01","ids":{"openalex":"https://openalex.org/W2270944813","doi":"https://doi.org/10.1177/204748730000700608","mag":"2270944813","pmid":"https://pubmed.ncbi.nlm.nih.gov/11189013"},"language":"en","primary_location":{"id":"doi:10.1177/204748730000700608","doi":"https://doi.org/10.1177/204748730000700608","is_oa":false,"landing_page_url":"https://doi.org/10.1177/204748730000700608","pdf_url":null,"source":{"id":"https://openalex.org/S4210239579","display_name":"European Journal of Cardiovascular Prevention & Rehabilitation","issn_l":"1741-8267","issn":["1741-8267","1741-8275"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cardiovascular Risk","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Zheng-Ming Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Zheng-Ming Chen","raw_affiliation_strings":["Correspondence to Dr Zheng-Ming Chen, Clinical Trial Service Unit, Radcliffe Infirmary, University of Oxford, Oxford OX2 6HE, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Correspondence to Dr Zheng-Ming Chen, Clinical Trial Service Unit, Radcliffe Infirmary, University of Oxford, Oxford OX2 6HE, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":null,"display_name":"Second Chinese Cardiac Study (CCS-2) Collaborative Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Second Chinese Cardiac Study (CCS-2) Collaborative Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40120149"],"apc_list":null,"apc_paid":null,"fwci":1.452,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.84313275,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"6","first_page":"435","last_page":"441"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myocardial-infarction","display_name":"acute myocardial infarction","score":0.9660000205039978},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.9869999885559082},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metoprolol","display_name":"metoprolol","score":0.8529999852180481},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.7319999933242798},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.921999990940094},{"id":"https://openalex.org/keywords/factorial-design","display_name":"factorial design","score":0.718999981880188},{"id":"https://openalex.org/keywords/major-vascular-events","display_name":"major vascular events","score":0.5519999861717224},{"id":"https://openalex.org/keywords/early-mortality","display_name":"early mortality","score":0.5910000205039978},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.4860000014305115},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.3630000054836273},{"id":"https://openalex.org/keywords/sample-size-calculation","display_name":"sample size determination","score":0.4440000057220459},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.3659999966621399},{"id":"https://openalex.org/keywords/thromboxane-a2","display_name":"thromboxane A2","score":0.5740000009536743},{"id":"https://openalex.org/keywords/adp-induced-platelet-aggregation","display_name":"ADP-induced aggregation","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9017461538314819},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.8596951961517334},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.8343563079833984},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.769977331161499},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.595428466796875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5501842498779297},{"id":"https://openalex.org/C2781280847","wikidata":"https://www.wikidata.org/wiki/Q409468","display_name":"Metoprolol","level":2,"score":0.5466906428337097},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.537419319152832},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4619169235229492},{"id":"https://openalex.org/C2909112448","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Platelet aggregation inhibitor","level":3,"score":0.41917282342910767},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.37550875544548035},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077144","descriptor_name":"Clopidogrel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008790","descriptor_name":"Metoprolol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013988","descriptor_name":"Ticlopidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013988","descriptor_name":"Ticlopidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/204748730000700608","doi":"https://doi.org/10.1177/204748730000700608","is_oa":false,"landing_page_url":"https://doi.org/10.1177/204748730000700608","pdf_url":null,"source":{"id":"https://openalex.org/S4210239579","display_name":"European Journal of Cardiovascular Prevention & Rehabilitation","issn_l":"1741-8267","issn":["1741-8267","1741-8275"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cardiovascular Risk","raw_type":"journal-article"},{"id":"pmid:11189013","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11189013","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular risk","raw_type":"Clinical Trial"},{"id":"mag:2966648279","doi":null,"is_oa":false,"landing_page_url":"https://www.cardioscience.ox.ac.uk/publications/661428","pdf_url":null,"source":{"id":"https://openalex.org/S201064403","display_name":"European Journal of Preventive Cardiology","issn_l":"2047-4873","issn":["2047-4873","2047-4881"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Preventive Cardiology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W186946926","https://openalex.org/W311320695","https://openalex.org/W1966953116","https://openalex.org/W1974140761","https://openalex.org/W1999964736","https://openalex.org/W2010839467","https://openalex.org/W2030530220","https://openalex.org/W2031390452","https://openalex.org/W2038252730","https://openalex.org/W2039496408","https://openalex.org/W2061429289","https://openalex.org/W2065144339","https://openalex.org/W2065697239","https://openalex.org/W2154583564","https://openalex.org/W2170309901","https://openalex.org/W2324061235","https://openalex.org/W2327850977","https://openalex.org/W2476265036","https://openalex.org/W2895806954","https://openalex.org/W4239471829"],"related_works":["https://openalex.org/W4301774590","https://openalex.org/W1972713566","https://openalex.org/W2347520852","https://openalex.org/W2284740101","https://openalex.org/W2107797912","https://openalex.org/W2506110194","https://openalex.org/W4233065669","https://openalex.org/W2044963048","https://openalex.org/W1553345686","https://openalex.org/W7101201214"],"abstract_inverted_index":{"Assessing":[0,145],"combined":[1,305],"anti-platelet":[2,44,68,283],"therapy":[3,148,168,182,229],"in":[4,16,95,107,137,149,162,169,175,205,217,230,236,257,259,310,437,460],"suspected":[5,98,150,356],"acute":[6,21,99,151,170,231,357],"myocardial":[7,22,100,152,171,232,358],"infarction":[8,101,153,359],"Aspirin":[9],"has":[10,326],"been":[11,159,327],"shown":[12],"to":[13,88,92,124,127,243,254,272,275,318,342,384,392,449,466],"be":[14,116,125,143,214,240,385,444,467],"effective":[15],"the":[17,32,35,108,173,200,206,278,282,286,322,353,363,379,395,402,415,418,440,450,470],"emergency":[18],"treatment":[19],"of":[20,34,59,61,72,110,132,165,227,277,281,314,324,352,355,394,401,408,417,426,432,445,453],"infarction.":[23,233],"It":[24],"irreversibly":[25],"inhibits":[26],"platelet":[27,36,55],"cyclo-oxygenase":[28],"and":[29,285,331,372,377,463],"thereby":[30],"prevents":[31],"formation":[33],"aggregating":[37],"agent":[38,45],"thromboxane":[39],"A2.":[40],"Clopidogrel":[41],"is":[42,222,337,464],"an":[43],"that":[46],"acts":[47],"by":[48,118,469],"a":[49,104,129,260,267,311,368],"different":[50,424,430],"mechanism,":[51],"inhibiting":[52],"adenosine":[53],"diphosphate-induced":[54],"aggregation.":[56],"Simultaneous":[57],"inhibition":[58,71],"both":[60],"these":[62],"pathways":[63],"might":[64,213],"produce":[65,103],"significantly":[66],"greater":[67,105],"effects":[69,280],"than":[70,114],"either":[73,393],"alone.":[74,121],"The":[75,457],"Second":[76],"Chinese":[77,140],"Cardiac":[78],"Study":[79],"(CCS-2)":[80],"will":[81,142,238,443],"reliably":[82],"determine":[83],"whether":[84],"adding":[85],"oral":[86],"clopidogrel":[87],"aspirin":[89,120],"for":[90,180,187,252,335,362,389],"up":[91,253],"4":[93,255],"weeks":[94,256],"hospital":[96,258],"after":[97],"can":[102,115],"reduction":[106,131,174],"risk":[109,219],"major":[111],"vascular":[112],"events":[113],"achieved":[117],"giving":[119],"In":[122,316],"order":[123,317],"able":[126],"detect":[128],"further":[130],"10-15%,":[133],"some":[134],"20,000-40,000":[135,320],"patients":[136,157,209,235,271,315,347],"over":[138,155],"1000":[139],"hospitals":[141,341],"randomized.":[144],"early":[146,176],"beta-blocker":[147,167,181,228,287],"Although":[154,211],"27,000":[156],"have":[158,367],"studied":[160],"previously":[161],"randomized":[163],"trials":[164],"short-term":[166],"infarction,":[172],"mortality":[177],"(513":[178],"(3.7%)":[179],"deaths":[183],"versus":[184],"586":[185],"(4.3%)":[186],"control":[188],"deaths)":[189],"was":[190],"only":[191],"just":[192],"conventionally":[193],"significant":[194],"(P":[195],"=":[196],"0.02)":[197],"and,":[198],"overall,":[199],"absolute":[201],"benefits":[202],"were":[203],"small":[204],"relatively":[207],"low-risk":[208],"studied.":[210],"there":[212,221,383],"worthwhile":[215],"benefit":[216],"higher":[218],"patients,":[220,321],"currently":[223],"little":[224],"routine":[225],"use":[226],"Hence,":[234],"CCS-2":[237,325,441],"also":[239,300],"randomly":[241],"allocated":[242],"receive":[244],"metoprolol":[245],"(intravenous":[246],"then":[247],"oral)":[248],"or":[249,295,390],"matching":[250],"placebo":[251],"2":[261,263],"x":[262],"factorial":[264],"design.":[265],"Such":[266],"design":[268,323],"allows":[269],"all":[270,405],"contribute":[273],"fully":[274],"assessment":[276],"separate":[279],"regimen":[284],"(without":[288],"any":[289],"material":[290],"effect":[291],"on":[292],"study":[293,364],"cost":[294],"sample":[296],"size":[297],"requirements)":[298],"whilst":[299],"providing":[301],"information":[302],"about":[303],"their":[304],"effects.":[306],"A":[307],"streamlined":[308],"trial":[309,396,403,458],"wide":[312,435],"range":[313],"randomize":[319],"streamlined:":[328],"data":[329],"collection":[330],"other":[332,406],"extra":[333],"work":[334],"collaborators":[336],"minimal,":[338],"allowing":[339],"busy":[340],"take":[343],"part":[344],"easily.":[345],"All":[346],"presenting":[348],"within":[349],"24":[350],"h":[351],"onset":[354],"are":[360,373,412],"eligible":[361],"provided":[365,378],"they":[366],"definite":[369],"ECG":[370],"abnormality":[371],"not":[374],"persistently":[375],"hypotensive,":[376],"doctor":[380,419],"responsible":[381],"considers":[382],"no":[386],"clear":[387],"indication":[388],"contraindication":[391],"treatments.":[397],"Apart":[398],"from":[399,428],"administration":[400],"treatments,":[404],"aspects":[407],"individual":[409],"patient":[410,427],"management":[411],"entirely":[413],"at":[414],"discretion":[416],"responsible.":[420],"By":[421],"including":[422],"many":[423,429],"types":[425,431],"hospital,":[433],"with":[434],"variation":[436],"ancillary":[438],"management,":[439],"results":[442],"direct":[446],"clinical":[447,455],"relevance":[448],"heterogeneous":[451],"realities":[452],"future":[454],"practice.":[456],"began":[459],"July":[461],"1999":[462],"expected":[465],"completed":[468],"year":[471],"2003.":[472]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}